Schedule 13G ownership disclosure
IMPRIMIS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 45323A201
Event date: 2016-12-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 125,000
- Percent of class
- 0.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-17-010243
- Form type
- SC 13G
- Filer
- HARROW, INC.
- CIK
- CIK 1360214
- Filed
- Feb 17, 2017
- Reporting period
- Dec 27, 2016
- Description
- Schedule 13G beneficial ownership